Recruiting soon

PhP-VXParents Helping Parents Program for Youth Vaping Cessation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Parents Helping Parents program

Behavioral
Who is being recruted

Vaping+4

+ Treatment Adherence and Compliance

+ Behavior

From 15 to 18 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: January 2026
See protocol details

Summary

Principal SponsorUniversity of Nebraska
Study ContactDaisy Dai, PhD
Last updated: December 13, 2025
Sourced from a government-validated database.Claim as a partner

Study start date: January 30, 2026

Actual date on which the first participant was enrolled.

The study focuses on creating and testing a new program called Parents-helping-Parents for Youth Vaping Cessation (PhP-VX). This program is designed to help parents support their children in quitting vaping. The study aims to see if this program is feasible and effective. It involves 100 pairs of parents and adolescents, who are recruited through an electronic health record system. Half of these pairs will participate in the PhP-VX program, while the other half will not receive any specific treatment during the study period. This research is important as it explores a novel way to tackle the issue of youth vaping, which is a growing concern for families and society, potentially offering new strategies for cessation. Participants in the PhP-VX program will engage in online lessons and receive personalized coaching sessions. Parents will have six bi-weekly, 30-minute sessions with a coach over Zoom to learn skills like effective communication and decision-making, and to receive support. Both groups will be surveyed at the start and then at 1, 3, and 6 months to track their e-cigarette use and knowledge. Some adolescents will also have the option to provide saliva samples to measure nicotine-related substances, further validating the study's findings. After the study, the control group will receive access to the online training materials. This structured approach helps evaluate the potential benefits of the program in reducing vaping among adolescents.

Official TitleParents Helping Parents for Youth Vaping Cessation (PhP-VX) 
NCT07207850
Principal SponsorUniversity of Nebraska
Study ContactDaisy Dai, PhD
Last updated: December 13, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 15 to 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

VapingTreatment Adherence and ComplianceBehaviorPatient Acceptance of Health CarePatient ParticipationSmokingHealth Behavior

Criteria

ADOLESCENT INCLUSION: * 15-18 * Report vaping in the previous 30 days * English literacy PARENT INCLUSION: * Biological, adoptive, stepparents, or adult guardian of adolescent participating * Have face-to-face contact with the adolescent at least one day per week during the study period * Access to a computer or mobile phone at home * Interested in helping adolescent quit e-cigarette/vape use

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Participants in this arm will receive the PhP-VX program.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

University of Nebraska Medical Center

Omaha, United StatesSee the location
Recruiting soonOne Study Center